bibliographic entry 5530276 [be/5530276]
https://w3id.org/oc/corpus/be/5530276

is a

• bibliographic reference

content

• Imagawa J, Tanaka H, Okada M, Nakamae H, Hino M, Murai K et al. Discontinuation of dasatinib in patients with chronic myeloid leukaemia who have maintained deep molecular response for longer than 1 year (DADI trial): a multicentre phase 2 trial. Lancet Haematol 2015; 2: e528–e535. PMID: 26686407

references

• https://w3id.org/oc/corpus/br/4706909